Congressional leaders begin probe on FDA oversight of plants in Puerto Rico
This article was originally published in Scrip
Executive Summary
Two congressional leaders have asked the US FDA to hand over inspection and enforcement data regarding its Puerto Rico office in a probe on whether the office has failed to adequately oversee pharmaceutical plants scattered throughout the island.